
Novartis Venture Fund
Corporate venture firm · Founded 1996 · Cambridge, MA · Boston ↗
Novartis's corporate venture fund, active since 1996, investing in biotechnology and biopharmaceutical companies across North America and Europe from teams in Cambridge, Massachusetts and Basel, Switzerland.
Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
This profile is unclaimed. Built from public sources. If you're a partner or employee at Novartis Venture Fund, you can claim it.
Claim this profileHow claiming worksKey numbers
Assets under management
$750M
Latest fund
LAST CHECKED NOV 2026
Funds
LAST CHECKED NOV 2026
Check size
$5M–$10M
Stages
SeedSeries ASeries B
Sectors
biotechnologybiopharmaceuticalslife sciences
FIGURES ARE AS PUBLISHED IN THE CATALOG RECORD 1 · PER-FIGURE AS-OF DATES ARE NOT YET IN THE CATALOG
Track record
Hits
- Bicycle Therapeuticsipo
Listed on NVF's own IPO-exits page: Bicycle Therapeutics completed its initial public offering (NASDAQ: BCYC) in 2019. NVF's stated investment range is USD 5-10M, with up to USD 25M allocated per company over its life.
Source: nvfund.com
Misses
Track record
Partners 2
- Florent Gros
Managing Director
Board seats
No public record - Steven Weinstein
Managing Director
Board seats
No public record
Reputation 2
No reputation score — basis not established for this firm.
- BioSpace: top corporate VCs in pharma
biospace.com
Contact
Published sources only
Published contact
- Website
- www.nvfund.com
Published sources only
GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.
SOURCE: FIRM WEBSITE, AS PUBLISHED 2
What founders say
Founder-submitted · Verified identity and relationship
No founder reviews yet
Be the first founder to share your experience with Novartis Venture Fund. Reviews come from founders whose identity and relationship have been verified.
Write the first reviewMethodology
Tier basis — AUM approximately $750M per the fund's own website falls in the $500M-$2B Tier 3 band. Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
Figures are shown as published; conflicting figures are never averaged. Review dimension scores appear only once three founders have reviewed this firm; profiles below that threshold do not appear in rated lists.
The catalog does not yet carry per-figure citations or as-of dates: every figure on this page traces to the catalog record listed below, and that limit is stated rather than papered over. Corrections with a source: Suggest a correction.
Source record 2
- [1]
DATABASE · GlassVC catalog — Catalog record for Novartis Venture Fund — provenance: GlassVC extended catalog, November 2026
↩ cites: AUM · Check size · Founded · HQ · Stages · Sectors · Track record · Reputation
- [2]
FIRM SITE · Novartis Venture Fund — Firm website, as published by the firm
PROFILE BUILT FROM PUBLIC SOURCES · 2 CATALOG SOURCES · LAST CHECKED NOV 2026
